Evidence map›Paper›PMID 41647575›Full record

ReviewFundamental research2026

Application of stellate ganglion modulation in mental disorders and the future prospects of physical therapies.

Yu'ang Liu, Linzi Liu, Zijing Deng, Yifang Zhou, Li Xiao, Yanqing Tang

Abstract readReview
In one paragraph

Review in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Advances in targeted and cellular therapies for relapsed/refractory mantle cell lymphoma: immunotherapeutic strategies and challenges.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu'ang LiuDepartment of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Linzi LiuDepartment of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Zijing DengDepartment of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Yifang ZhouDepartment of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Li XiaoSleep Medicine Center, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Yanqing TangDepartment of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of mental disorders faces significant challenges due to their complex etiology and the limitations of existing therapies. Neuromodulation has emerged as a promising approach for managing these conditions. Among the various neuromodulatory strategies, stellate ganglion modulation (SGM) specifically targets the sympathetic nervous system by inhibiting neural activity at the cervical stellate ganglion (SG). Stellate ganglion block (SGB), a chemical form of SGM achieved through local anesthetic injection into the SG, suppresses sympathetic nerve impulses to the head, neck, and upper limbs. Evidence suggests that SGB offers a favorable safety profile and demonstrates notable efficacy in treating post-traumatic stress disorder. Moreover, preliminary findings indicate its potential in managing depression and sleep disorders. Current hypotheses propose that SGB alleviates psychological symptoms via two pathways: ascending regulation, which modulates neuroendocrine activity and neuroinflammation, and descending regulation, which influences cardiovascular and digestive functions, thereby engaging the heart-brain and gut-brain axes. Recently, physical energy-based modalities for SGM, including electrical, magnetic, optical, thermal, and ultrasonic stimulation, have been explored as alternatives to conventional chemical modulation. Invasive physical methods such as electroacupuncture and radiofrequency ablation show preliminary efficacy and safety, while noninvasive approaches provide simpler and safer options, with some evidence of benefit in conditions such as arrhythmia. However, clinical validation in psychiatric populations remains limited. Despite the therapeutic promise of physical SGM, key questions persist regarding its mechanisms, efficacy, and safety in mental disorders. Future research should aim to expand preclinical studies, verify these techniques in psychiatric populations, standardize stimulation parameters, develop closed-loop feedback systems, and assess long-term outcomes.

Indexed as

Mental disordersNeuromodulationPhysical therapyStellate ganglionSympathetic nervous system

Identifiers

PMID41647575
PMCPMC12869746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.